Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT). (May 2023) - Sayyed, A.; Altareb, M.; Chen, C.; Gerbitz, A.; Kim, D.; Lam, W.; Law, A.; Lipton, J.; Michelis, F.; Novitzky-Basso, I.; Viswabandya, A.; Kumar, R.; et al.